Navacilla, Baby Girl .

HRN: 22-56-56  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/11/2023
AMPICILLIN 500MG (VIAL)
02/11/2023
02/18/2023
IV
130mg
Q12hours
Neonatal Pneumonia
Waiting Final Action 
02/11/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/11/2023
02/18/2023
IV
39mg
OD
Neonatal Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: